SOMATOSTATIN, also known as somatotropin-release inhibiting factor (SRIF), was first characterized in 1973 (Brazeau et al. 1973) . It is a cyclic polypeptide with two biologically active isoforms: SRIF-14 and SRIF-28. This cyclic polypeptide has broad inhibitory effects on the secretion of hormones such as growth hormone in the hypothalamus and insulin and glucagon in the pancreas. Somatostatin is distributed widely throughout both the central and peripheral nervous system and in other organs including the pancreas, gut, adrenal glands, thyroid, and in particular, the kidney (Benali et al. 2000; Moller et al. 2003; Bates et al. 2004a; Pinter et al. 2006) .
The biological effects of somatostatin are exerted through binding to the G protein-coupled somatostatin receptors (sst) in the plasma membrane (Schonbrunn and Tashjian 1978; Krantic 2000; Weckbecker et al. 2003) . Five isoforms of sst including the spliced variants (sst 2A and sst 2B ) have been identified (Benali et al. 2000; Moller et al. 2003) . They belong to the heptahelical family of G protein-coupled receptors and have high affinity binding with endogenous somatostatin. A series of synthetic somatostatin analogs with different affinity for the subtypes have been developed for research and clinical use (Moller et al. 2003; Weckbecker et al. 2003) , though the internalization of ssts evoked by agonists may abrogate their effects (Kreienkamp et al. 1998; Cescato et al. 2006; Roosterman et al. 2007 ). The signaling pathways for the different ssts are thought to vary and are likely to explain why the activation of different ssts displays disparate effects, such as anti-proliferation and anti-angiogenesis effects (Bruns et al. 1994; Danesi et al. 1997) , whereas others, such as sst 3 , are involved in apoptosis induction (Sharma et al. 1996; Moller et al. 2003) . These processes of cell proliferation, apoptosis, and angiogenesis are important in renal hemodynamics and function.
In the kidney, somatostatin is reported to reduce glomerular filtration rate and decrease renal blood flow through direct renal vasoconstriction (Schmidt et al. 2002) . At a cellular level, somatostatin exerts an anti-diuretic affect by depressing free water clearance and by an inhibition of vasopressin-induced water permeability in the distal tubules, thus reducing urine volume (Ray et al. 1993) . It has been shown that somatostatin suppresses the release of aldosterone and renin (Jones et al. 1984; Sieber et al. 1988; Mazzocchi et al. 1992; Reubi et al. 1993 ). In addition, somatostatin may inhibit mesangial cell proliferation and contraction (Garcia-Escribano et al. 1993; Garcia-Escribano et al. 1994) , and epidermal growth factor induced human proximal tubular epithelial cell proliferation (Hatzoglou et al. 1996; Turman and Apple 1998) . Somatostatin and its synthetic analogs have been shown to inhibit experimental angiogenesis in in vitro and in vivo models (Danesi et al. 1997; Adams et al. 2004 ). Some analogs have been used for somatostatin receptor scintigraphy for kidney cancer imaging and radiotherapy (McCaffrey et al. 2000; Vegt et al. 2006) .
There are several reports on the expression of somatostatin or ssts in mouse (Bates et al. 2004b ), rat (Kurokawa et al. 1983; Bruno et al. 1993; Kimura et al. 2001) , and human kidney (Yamada et al. 1992; Balster et al. 2001 ) using northern blotting, RT-PCR, and immunostaining; however, the immunostaining for all sst subtypes and the spliced isoforms in kidney are still unknown, and no data are available for the diseased human kidney. In this study, we examined the distribution of somatostatin and somatostatin receptor subtypes (sst 1-5 ) in normal human kidney using immunohistochemistry, immunofluorescence, and real-time RT-PCR and the expression patterns of ssts in IgA nephropathy.
Materials and Methods

Tissue Retrieval
Paraffin blocks were obtained from nephrectomy and renal biopsy samples at Hull and East Yorkshire NHS Trust (Hull, UK) with approval of the local ethics committee (Reference Elsy no. CHH 341). Twenty-five normal and four IgA nephropathy human kidney samples from patients undergoing nephrectomy or diagnostic renal biopsy were used in this study. The criteria for normal kidney tissue samples are based on pathological diagnosis rather than from healthy volunteer subjects. Four patients presenting classical IgA nephropathy underwent renal biopsy, and the diagnosis was confirmed based on pathological findings that included expansion of the mesangial matrix, proliferation of mesangial cells (hypercellularity), and immunofluorescent staining for IgA and C3 and occasional IgG in the mesangium and to a lesser extent the glomerular capillary wall.
Immunohistochemistry
Paraffin-embedded kidney tissue sections (3 mm thickness) were immunostained for sst l , sst 2A , sst 2B , sst 3 , sst 4 , and sst 5 using polyclonal rabbit antisera (Gramsch Laboratories; Schwabbausen, Germany). Somatostatin was stained by rabbit polyclonal anti-human somatostatin antibody (AHP533; AbD Serotec, Kidlington, UK). Two staining methods were used to characterize sst expression. sst 1 , sst 2B , sst 3 , and sst 5 underwent tyramide signal amplification, and somatostatin, sst 2A , and sst 4 underwent Dako-catalyzed signal amplification. All sections underwent deparaffinization, endogenous peroxidase blocking, heat-induced epitope retrieval by microwave heating in citrate buffer, pH 6, for 20 min, and avidin/biotin blocking (Vector Laboratories; Peterborough, UK), along with blocking in nonspecific serum to ensure that staining was specific. sst 1 , sst 2B , sst 3 , and sst 5 primary antibodies were incubated at 1:5000 overnight at 4C, followed by biotinylated antimouse/rabbit immunoglobulins (Dako; Cambridgeshire, UK) at 1:1000 for 18 min. For somatostatin, the anti-somatostatin antibody as a dilution of 1:100 was used (Hall et al. 2002) . sst 2B and stt 4 underwent incubation at a dilution of 1:10,000 overnight at 4C, using Dako Catalyzed Signal Amplification Peroxidase System (Dako), with a biotinylated secondary link antibody and streptavidin-biotin complex. All staining was visualized using 3,3′-diaminobenzidine and was counterstained with hematoxylin. Immunostaining in the various parts of the kidney sections (in relation to its intensity or positivity) was characterized and was scored as 0 (negative), 1 (weak staining), 2 (stained), or 3 (strong staining). Negative controls included the omission of the primary antibody or incubation with normal goat serum diluted 1:20 with TBS or normal rabbit serum diluted 1:2500 for the same period of time as the primary antibody.
Immunofluorescence
Frozen kidney tissue sections (20 mm thickness) were fixed with 4% paraformaldehyde and permeabilized by incubation in 220C methanol for 1 min and 0.1% Triton X-100 in PBS for 3 hr at room temperature. Sections were incubated in 1% BSA to block nonspecific binding and incubated in the appropriate sst primary antibody at 1:500 dilution in PBS with 1% BSA at 4C overnight (Gramsch Laboratories). Tissue sections were washed three times with PBS and incubated in the af-finity purified sheep anti-rabbit IgG conjugated with FITC (Sigma; Poole, UK) at a dilution of 1:160 for 3 hr at room temperature. Sections were double stained by incubation for 4 hr in the Cy3-conjugated monoclonal anti-a-smooth muscle actin (SMA; Sigma) at a dilution of 1:200. After three washes with PBS, sections were coverslipped with Vectashield mounting medium with 4′-6-diamidino-2-phenylindole (DAPI) (Vector Laboratories). Staining was photographed using Bio-Rad Radiance 2100 confocal microscope and acquisition software (Bio-Rad; Hercules, CA).
Quantitative RT-PCR Total RNA was extracted from the snap-frozen normal kidney samples in liquid nitrogen using Trizol (Invitrogen; Paisley, UK) and treated with DNase I (Invitrogen) to remove genomic DNA contamination before reverse transcription in the presence of RNasin RNase inhibitor (Promega; Southampton, UK). The RNA was reverse transcribed with Moloney murine leukemia virus reverse transcriptase using random primers (Invitrogen). Quantitative RT-PCR was preformed using GeneAmp 5700 sequence detection system (Applied Biosystems; Foster City, CA). The forward and reverse primers and probes for sst 1-5 were synthesized by MWG-Biotech (Ebersberg, Germany) ( Table 1 ). The internal probes were labeled at the 5′ ends with the reporter fluorochrome 6-carboxyfluorescein (FAM) and at the 3′ ends with the quencher fluorochrome 6-carboxytetramethylrhodamine (TAM-RA). Each reaction volume was 25 ml and contained 13 TaqMan Universal Master Mix (Applied Biosystems), 5 ml cDNA, 0.75 ml 300 nM forward primer, 0.75 ml 300 nM reverse primer, and 0.38 ml 150 nM internal probe. The human b-glucuronidase housekeeping gene (GUSB; Applied Biosystems) was used as an internal standard. Water was used as a non-template control. Non-reverse-transcribed samples were run in parallel to confirm that positive results were not caused by amplification of genomic DNA. Human genomic DNA or plasmid somatostatin receptor cDNAs were used as positive controls. The PCR cycle consisted of an initial cycle of 50C for 2 min followed by 95C for 10 min, 50 repeated cycles of 95C for 15 sec (denaturation), and 50C for 1 min (primer annealing and extension).
Results
Distribution of Somatostatin
The anti-somatostatin can recognize both SRIF 14 and SRIF-28 (Hall et al. 2002) . Staining was positive in human tubular epithelial cells and glomerular cells, particularly for nuclei that were more intensively stained. Epithelial cells in both the proximal convoluted tubule (PCT) and distal convoluted tubule (DCT) were clearly stained ( Figure 1A ). Epithelial cells in the urine pole were also positive. However, we found about one half the cells in the glomeruli were stained, and some were negative. The positively stained cells could be glomerular epithelial cells (podocytes) and vascular endothelial cells, because the staining pattern was different from that for mesangial cells (Balster et al. 2001; Bates et al. 2004a ).
The immunostaining on the sections of IgA nephropathy showed a staining pattern that was similar to that of normal kidney ( Figure 1B ).
Somatostatin Receptors in Normal Kidney
We examined the protein distribution of sst 1-5 in paraffin-embedded sections of normal human kidney using samples from nephrectomy or renal biopsy specimens. The rabbit polyclonal anti-somatostatin receptor antibodies used in this study have been extensively characterized in previous studies on native tissues (Schulz et al. 1998a (Schulz et al. ,b,2000 Green et al. 2002; Hall et al. 2002; Stafford et al. 2003 Stafford et al. ,2004 Notas et al. 2004; Taniyama et al. 2005; Vezzosi et al. 2005; Druckenthaner et al. 2007) , the cell lines overexpressing somatostatin genes (Schulz et al. 1998b (Schulz et al. ,2000 , and controls with antibodies absorbed with antigenic peptide (Schulz et al. 1998a (Schulz et al. ,b,2000 Notas et al. 2004; Druckenthaner et al. 2007 ). These antibodies targeting to the C terminus of the receptors had no cross-reactivity among the subtypes (Schulz et al. 1998a (Schulz et al. ,b,2000 . The specificity of these antibodies was examined by positive staining using human anterior pituitary, pancreas, endometrium, acoustic neuroma, and endothelial cells as previously reported (Green et al. 2002; Stafford et al. 2003 Stafford et al. ,2004 Adams et al. 2005 ) and negative staining using normal rabbit or goat sera. 
sst, somatostatin receptor subtype.
Tubular Staining. The PCTs, DCTs, and loop of Henle (LH) were identified by their histological characteristics on the tissue sections. Positive immunostaining for all isoforms of somatostatin receptors (sst 1 , sst 2A , sst 2B , sst 3 , sst 4 , and sst 5 ) was found in the PCTs, DCTs, and LH ( Figure 2) . The staining pattern for nuclear areas was more condensed for all ssts, but cytoplasmic staining was also observed for sst 1 , sst 2B , and sst 5 .
Glomerular Staining. The glomerular cells were positively stained by anti-sst 1 , anti-sst 2B , anti-sst 3 , and antisst 5 antibodies and weakly stained by anti-sst 2A and anti-sst 4 . Staining for sst 1 and sst 4 was predominantly cytoplasmic, whereas staining for sst 2B , sst 3 , and sst 5 was observed in both nuclear and cytoplasmic areas. Positive cell types in the glomeruli were not ascertained in the paraffin sections, but proximal tubular epithelia starting from glomerular urinary poles were clearly labeled by anti-sst 1 , anti-sst 2B , anti-sst 3 , and anti-sst 5 (Figure 2 ).
Dual Fluorescent Labeling With Anti-a-SMA. To confirm the cell types and determine the location of the somatostatin receptors in a cell, fluorescent immunostaining was performed using frozen tissue sections of normal human kidney. a-SMA was used as a cell marker of mesangial cells (Johnson et al. 1991) , and von Willebrand factor (VWF) was used as a marker of vascular endothelial cell (Pusztaszeri et al. 2006) . We found the anti-a-SMA antibody strongly stained vascular smooth muscle cells (data not shown) and only weakly stained mesangial cells in normal kidney tissue sections. Overlapping staining of sst 1 , sst 2B , sst 4 , and sst 5 with a-SMA was observed (Figure 3 ), suggesting that glomerular mesangial cells express sst 1 , sst 2B , sst 4 , and sst 5 . Some glomerular cells (possibly capillaries) were labeled with anti-sst 2A , but the pattern was different from mesangial cells that were labeled with anti-a-SMA, suggesting sst 2A may not be present in mesangial cells. The staining for sst 1 , sst 4 , and sst 5 was predominantly cytoplasmic (Figures 2 and 3) . Some cells in the glomeruli were stained with anti-VWF but not colocalized with anti-a-SMA (Figure 3 ), suggesting they were more likely endothelial cells.
Somatostatin Receptors in IgA Nephropathy Kidney
Paraffin-embedded biopsy samples from four patients diagnosed with IgA nephropathy were stained with anti-somatostatin antibodies, and normal kidney tissue sections were stained in parallel as a control. Like the staining in normal kidney, we found all somatostatin receptors (sst 1-5 ) were positive in sections of IgA nephropathy kidney, but staining for sst 1 , sst 2B , sst 4 , and sst 5 was much stronger than that seen in normal kidney sections. sst 3 staining was similar or perhaps less intense in the glomeruli in comparison to controls (Figure 4 ). This increased staining was not limited to the glomeruli but was also found in the proximal and distal tubules. In the IgA nephropathy kidney samples, more staining was observed in the cytoplasm for sst 1 , sst 2B , sst 4 , and sst 5 . The mean data for intensity of staining scores are shown in Figures 4G-4I .
Detection of Somatostatin Receptor mRNAs in Human Kidney
The mRNA of sst 1-5 in the normal kidney was detected by RT-PCR ( Figure 5A ). The spliced isoform of sst 2A and sst 2B were also detected by an isoform-specific primer set ( Figure 5B ). Because sst 4 has no introns, we used real-time RT-PCR to quantitatively compare mRNA after genomic DNA digestion. The mRNA expression of sst 1-5 was confirmed. sst 1 , sst 2 , and sst 5 were expressed consistently at high levels in four separate kidney samples, but very low levels of sst 3 and sst 4 were observed. The internal fluorescent probes used for real-time PCR were specific for the individual amplicon, because no fluorescent signal was observed if a nonspecific internal probe was used as a control ( Figure 5C ).
Discussion
In this study, we showed that somatostatin and all five somatostatin receptor subtypes including spliced variants are widely expressed in normal kidney. These receptors are predominantly distributed in the tubular epithelium and glomerular mesangial cells. In addition, we showed for the first time that somatostatin receptors are expressed more highly in IgA nephropathy human kidney and found that several isoforms (sst 1 , sst 2B , sst 4 , and sst 5 ) are upregulated in this inflammatory kidney disease. These data provide new evidence in the understanding of the role of somatostatin analogs in the normal and diseased kidney. There are several reports on the expression of somatostatin and somatostatin receptors in animal and human kidney tissues detected by northern blotting or RT-PCR at the mRNA level or the tissue distribution by immunostaining (Table 2) . Northern blotting is an insensitive method for mRNA detection that has been widely used in previous studies, and it has been replaced by RT-PCR or real-time RT-PCR. Using realtime PCR, we found all five subtypes of somatostatin receptors exist in kidney tissue. To avoid genomic DNA contamination, we treated the RNA samples with DNase and also set negative and positive (genomic DNA or plasmid somatostatin receptor cDNA) controls in parallel for RT-PCR. Because some iso- forms of ssts, such as sst 4 , have no introns, we used realtime RT-PCR to quantitatively compare the groups with and without reverse transcriptase treatment. We found a clear shift of the real-time PCR curve between the groups, which confirms the presence of somatostatin receptor mRNAs.
Immunostaining with specific antibodies is usually important for protein localization. sst 1 has been reported exclusively in tubules in an earlier study (Balster et al. 2001 ), but we found that sst 1 clearly stained in the glomerular cells (mesangial cells), as shown in both paraffin-embedded and frozen sections. This may be because of the antibody used, which targeted the 57 amino acid N terminus (Balster et al. 2001 ). However, we used the peptide-specific anti-sst 1 antibody targeting the eight amino acids (CTSRITTL) in the C terminus. The specificity of the sst 1 antibody used in this study has been extensively examined in many studies (Schulz et al. 1998a (Schulz et al. ,b,2000 Green et al. 2002; Stafford et al. 2003 Stafford et al. ,2004 Adams et al. 2005) . Therefore, our results suggest that sst 1 is widely expressed in the tubules and glomeruli. We noted that staining was possibly Figure 5 Detection of somatostatin receptor mRNA in kidney by RT-PCR. (A) PCR products were shown in the 2% agarose gel stained with ethidium bromide. The expected size of PCR amplicons is 68 bp for sst 1 , 61 bp for sst 2 , 86 bp for sst 3 , 68 bp for sst 4 , and 79 bp for sst 5 . (B) The spliced variants of sst 2A [Lane 1, 332 bp with reverse primer (1); Lane 2, 475 bp with reverse primer (2)] and sst 2B (95 bp) were detected by RT-PCR. The housekeeping gene, GAPDH (326 bp), was used as control. The sst 2B product was confirmed by direct sequencing. (C) An example of real-time PCR detection of somatostatin mRNA in kidney. No product was detected if the nonspecific probes for somatostatin were used, such as sst 1 probe used for detection of sst 2 (data not shown).
both cytosolic and nuclear. Because of the method used with histochemical staining of paraffin sections, we cannot clearly delineate the exact intracellular location of proteins, and hence it is difficult to be more specific. We know that several somatostatin receptors have the property of internalization, suggesting the localization in cytosol and around nuclear area is possible. In addition, the laser confocal pictures (Figure 3 ) also suggest that the staining may not be in the nuclei (blue staining with DAPI).
Both sst 2A and sst 2B isoforms are predominantly located in the tubules. Staining for sst 2B was much stronger than that for sst 2A in the human kidney, suggesting that the expression of the sst 2B isoform could be higher. This result is in accordance with reports of sst 2A being expressed in kidney tubules (Kimura et al. 2001; Taniyama et al. 2005 ). In addition, the autoradiography data with a high affinity sst 2 analog [ 177 Lu-DOTA] octreotate also showed the binding in proximal tubules and glomeruli (Melis et al. 2005) . The renal radiation injury caused by the sst 2 -specific radioactive octreotide further supports the presence of sst 2 in human kidney (Rolleman et al. 2007 ).
The finding of somatostatin and somatostatin receptor subtypes (sst 1 , sst 2B , sst 3 , sst 4 , and sst 5 ) within the mesangial cells suggests a role for their regulation in renal function (Ray et al. 1993; Schmidt et al. 2002) . The upregulation of somatostatin receptors in IgA nephropathy suggests the involvement of these receptors in inflammatory kidney disease, especially for glomerular damage caused by abnormal proliferation of mesangial cells or glomerular podocytes. Others have shown that somatostatin can inhibit the synthesis of insulin-like growth factor, which is an important regu-latory protein, leading to mesangial cell proliferation and hyperfiltration as seen in IgA and diabetic nephropathy (Serri et al. 1992) . Somatostatin analogs, such as octreotide that mainly binds to sst 2 and sst 5 , have been used for the treatment of some tumors and could also have potential effects for renal disorders through the suppression of mesangial cell proliferation (Uemasu et al. 1990; Uemasu et al. 1992; Dasgupta 2004) .
In conclusion, we present the tissue distribution of somatostatin and all five somatostatin receptor subtypes in histologically normal and IgA nephropathy human kidney, with increased somatostatin receptor expression in IgA nephropathy kidney. The ubiquitous distribution of these receptors in glomeruli and tubules is consistent with the observation that somatostatin or its analogs may affect function. The findings of this study could also provide a histological basis for the treatment of autosomal-dominant polycystic kidney with somatostatin analogs (Ruggenenti et al. 2005; Grantham 2006) or the related kidney side effects using somatostatin peptide-based radiation therapy (Rolleman et al. 2007 ).
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